Anticoagulation in COVID-19: current concepts and controversies
A Chandra, U Chakraborty, S Ghosh… - Postgraduate Medical …, 2022 - academic.oup.com
Rising incidence of thromboembolism secondary to COVID-19 has become a global
concern, with several surveys reporting increased mortality rates. Thrombogenic potential of …
concern, with several surveys reporting increased mortality rates. Thrombogenic potential of …
[PDF][PDF] Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19-a Swiss consensus statement by the Working Party Hemostasis
A Casini, L Alberio, A Angelillo-Scherrer… - Swiss medical …, 2020 - zora.uzh.ch
Growing evidence from multiple retrospective cohorts indicates that hospitalised COVID-19
patients often could suffer from an excessive coagulation activation leading to an increased …
patients often could suffer from an excessive coagulation activation leading to an increased …
[HTML][HTML] Risk of venous thromboembolism in patients with COVID‐19: a systematic review and meta‐analysis
Background Venous thromboembolism (VTE) is frequently observed in patients with
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …
Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study
N Munoz-Rivas, A Abad-Motos, B Mestre-Gomez… - Thrombosis research, 2021 - Elsevier
Background Incidence of thrombotic events associated to Coronavirus disease-2019
(COVID-19) is difficult to assess and reported rates differ significantly. Optimal …
(COVID-19) is difficult to assess and reported rates differ significantly. Optimal …
Different anticoagulant regimens, mortality, and bleeding in hospitalized patients with COVID-19: a systematic review and an updated meta-analysis
We conducted a systematic review and a meta-analysis to assess the association of
anticoagulants and their dosage with in-hospital all-cause mortality in COVID-19 patients …
anticoagulants and their dosage with in-hospital all-cause mortality in COVID-19 patients …
Anticoagulation outcomes in hospitalized Covid‐19 patients: A systematic review and meta‐analysis of case‐control and cohort studies
Background: Coagulopathy and thromboembolic events are common in Covid‐19 patients
and are poor prognostic factors. Controversy exists regarding the potential of …
and are poor prognostic factors. Controversy exists regarding the potential of …
Anticoagulation in COVID-19: a systematic review, meta-analysis, and rapid guidance from Mayo Clinic
RD McBane II, VDT Roldan, AS Niven, RK Pruthi… - Mayo Clinic …, 2020 - Elsevier
A higher risk of thrombosis has been described as a prominent feature of coronavirus
disease 2019 (COVID-19). This systematic review synthesizes current data on thrombosis …
disease 2019 (COVID-19). This systematic review synthesizes current data on thrombosis …